Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$625K Sell
15,357
-3,247
-17% -$119K 0.01% 869
2026
Q1
$647K Buy
18,604
+1,494
+9% +$47.7K 0.01% 808
2025
Q4
$449K Buy
17,110
+7,139
+72% +$178K 0.01% 970
2025
Q3
$262K Sell
9,971
-59
-0.6% -$1.42K ﹤0.01% 1311
2025
Q2
$249K Sell
10,030
-1,472
-13% -$36.1K ﹤0.01% 1291
2025
Q1
$302K Sell
11,502
-555
-5% -$15K ﹤0.01% 1085
2024
Q4
$300K Sell
12,057
-4,630
-28% -$107K ﹤0.01% 1187
2024
Q3
$345K Buy
16,687
+4,929
+42% +$99.8K 0.01% 1119
2024
Q2
$238K Buy
+11,758
New +$233K ﹤0.01% 1233

Other funds holding AROC

Choreo LLC's AROC Position: Q2 2026 in Review

Choreo LLC reduced its Archrock (AROC) stake by 17% in Q2 2026, selling an estimated $119K and leaving 15,357 shares worth $625K. The position accounts for 0.01% of the portfolio, ranked #869.

Choreo LLC first reported a position in AROC in Q2 2024 and has held it in 9 quarters since. The position peaked at $647K in Q1 2026. 452 funds tracked by Wall St. Rank hold AROC as of Q2 2026.

  • Choreo LLC held 15,357 shares of Archrock worth $625K as of Q2 2026.
  • Choreo LLC sold 3,247 Archrock shares in Q2 2026, an estimated $119K.
  • Archrock made up 0.01% of Choreo LLC's portfolio in Q2 2026, its #869 holding.
  • Choreo LLC first reported a position in Archrock in Q2 2024 and has held it in 9 quarters since.
  • Choreo LLC's Archrock position peaked at $647K in Q1 2026.
  • 452 funds tracked by Wall St. Rank held Archrock as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.